HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Camilla Gesi Selected Research
Camilla Gesi Research Topics
Disease
6
Separation Anxiety (Separation Anxiety Disorder)
01/2017 - 09/2005
3
Mental Disorders (Mental Disorder)
05/2021 - 09/2005
3
Schizophrenia (Dementia Praecox)
04/2021 - 01/2019
3
Mood Disorders (Mood Disorder)
01/2019 - 01/2010
3
Bipolar Disorder (Manic Depressive Psychosis)
01/2018 - 01/2010
3
Panic Disorder (Panic Attack)
01/2010 - 09/2005
2
Anxiety Disorders (Anxiety Disorder)
11/2019 - 05/2015
2
Substance-Related Disorders (Drug Abuse)
11/2019 - 01/2018
1
Major Depressive Disorder (Major Depressive Disorders)
01/2021
1
Cognitive Dysfunction
01/2019
1
Inflammation (Inflammations)
01/2016
1
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2016
1
Traumatic Brain Injuries (Traumatic Brain Injury)
01/2016
1
Neurodevelopmental Disorders
01/2016
1
Cardiovascular Diseases (Cardiovascular Disease)
04/2014
1
Non-ST Elevated Myocardial Infarction
04/2014
1
ST Elevation Myocardial Infarction
04/2014
1
Mania (Manias)
05/2012
1
Depressive Disorder (Melancholia)
11/2009
Drug/Important Bio-Agent (IBA)
3
Proteins (Proteins, Gene)
FDA Link
01/2010 - 04/2008
2
Antidepressive Agents (Antidepressants)
IBA
01/2021 - 01/2019
2
Antipsychotic Agents (Antipsychotics)
IBA
01/2021 - 01/2019
2
cariprazine
IBA
01/2021 - 01/2019
2
Ligands
IBA
01/2010 - 04/2008
2
A-factor (Streptomyces)
IBA
01/2010 - 04/2008
2
PK 11195 (PK11195)
IBA
01/2010 - 04/2008
2
Oxytocin (Pitocin)
FDA Link
Generic
11/2009 - 07/2009
2
GABA-A Receptors (GABA(A) Receptor)
IBA
04/2008 - 09/2005
1
Psychotropic Drugs (Psychoactive Drugs)
IBA
05/2021
1
Silver Sulfadiazine (SSD)
FDA Link
Generic
04/2021
1
Amisulpride (Solian)
IBA
01/2019
1
Adrenergic Agonists (Adrenergic Receptor Agonist)
IBA
01/2018
1
Benzodiazepines
IBA
01/2018
1
Diuretics
IBA
01/2018
1
Glycogen Synthase (Synthase I)
IBA
01/2016
1
Lithium
IBA
01/2016
1
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
01/2016
1
erucylphosphocholine
IBA
05/2015
1
3,4-methylenedioxyethamphetamine (MDEA)
IBA
04/2014
1
gamma-Aminobutyric Acid (GABA)
IBA
05/2012
1
Glutamic Acid (Glutamate)
FDA Link
05/2012
1
Biomarkers (Surrogate Marker)
IBA
01/2010
1
Neurotransmitter Agents (Neurotransmitter)
IBA
11/2009
Therapy/Procedure
3
Therapeutics
01/2021 - 01/2017
1
Length of Stay
11/2019
1
Pain Management
10/2017